Study discovers new treatment for rare eye disease that prev

Teprotumumab, a minimally invasive insulin-like growth factor I blocking antibody, has been shown to enhance symptoms, appearance, and quality of life in patients with thyroid eye disease, according to a study.

Related Keywords

Raymond Douglas , Drug Administration , Thyroid Eye Disease Program At Cedars , New England Journal , Thyroid Eye Disease Program , Wiley Chambers , Ophthalmology Products , Drug Evaluation , Study , Iscovers , Few , Treatment , Or , Mare , Eye , Disease , Hat , Prevent , Blindness , News , Ews India ,